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Primordial germ cell (PGC) development is charac-
terized by global epigenetic remodeling, which re-
sets genomic potential and establishes an epigenetic
ground state. Herewe recapitulate PGC specification
in vitro from naive embryonic stem cells and charac-
terize the early events of epigenetic reprogramming
during the formation of the human and mouse germ-
line. Following rapid de novo DNAmethylation during
priming to epiblast-like cells, methylation is globally
erased in PGC-like cells. Repressive chromatin
marks (H3K9me2/3) and transposable elements are
enriched at demethylation-resistant regions, while
active chromatin marks (H3K4me3 or H3K27ac) are
more prominent at regions that demethylate faster.
The dynamics of specification and epigenetic re-
programming show species-specific differences, in
particular markedly slower reprogramming kinetics
in the human germline. Differences in developmental
kineticsmay be explained by differential regulation of
epigenetic modifiers. Our work establishes a robust
and faithful experimental system of the early events
of epigenetic reprogramming and regulation in the
germline.
INTRODUCTION
Primordial germ cells (PGCs) are the precursors of the fully differ-
entiated gametes, oocytes, and sperm, establishing during their
development the prerequisites of the totipotent state. Upon their
specification PGCs undergo global epigenetic reprogramming,
erasing epigenetic memory and re-establishing an epigenetic
ground state (Clark, 2015; von Meyenn and Reik, 2015; Reik
and Surani, 2015). Our basic understanding of mammalian
PGC specification and epigenetic reprogramming stems largely
from work in the mouse. However, recent work is beginning to
shed light on human germline development and epigenetic re-104 Developmental Cell 39, 104–115, October 10, 2016 ª 2016 The A
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mouse, after exit from naive pluripotency in the inner cell mass
(ICM) and priming for differentiation, a small cluster of 40
PGCs is detectable in the epiblast around embryonic day 7.25
(E7.25). Subsequently PGCs migrate through the hindgut to the
developing genital ridges (E8–E10.5) where they proliferate
extensively before sexual differentiation commences. Human
PGCs (hPGCs) are specified around E12–E16 (developmental
week 2), and, while the early migratory phase (weeks 3–5) of
in vivo hPGC development is currently not accessible to experi-
mental analysis, gonadal hPGCs have recently been isolated and
characterized molecularly (Gkountela et al., 2015; Guo et al.,
2015; Tang et al., 2015). This in vivo work has shown that hPGCs
are characterized by the expression of known PGC marker
genes such as BLIMP1, PRDM14, or DPPA3 but also express
human specific genes such as SOX17. Similar to epigenetic re-
programming in mouse PGCs (mPGCs), in vivo hPGCs have
erased DNAmethylation globally by week 5.5, presumably start-
ing during the migratory phase, resulting in a hypomethylated
epigenetic ground state.
Given the relative inaccessibility and difficulties in manipu-
lating PGCs in vivo, the development of an in vitro differentiation
system is highly desirable. Spontaneously differentiating human
and mouse cells expressing germ cell markers isolated from
embryoid bodies (EBs) were initially used as a proxy for in vitro
generation of gametes or PGCs (Daley, 2007; Saitou and Yamaji,
2010), and some erasure of DNAmethylation was documented in
the mouse system (Vincent et al., 2013). However, only more
recent studies have demonstrated the potential to faithfully
reconstitute early mouse and human PGC specification in vitro
(Hayashi et al., 2011; Irie et al., 2015; Sasaki et al., 2015; Sugawa
et al., 2015). Some limited results suggested that DNA methyl-
ation reprogramming takes place, but no systematic genome-
scale analysis has been carried out (Hayashi et al., 2011; Tang
et al., 2015).
The specification of mouse PGC-like cells (mPGCLCs) closely
recapitulates in vivo PGC specification (Hayashi et al., 2011).
Naive ICM-like embryonic stem cells (ESCs) (Nichols and Smith,
2012) are differentiated to epiblast-like cells (EpiLCs), which
closely mimic the in vivo epiblast state around E6.25, when
mPGCs are first specified. ‘‘Germline-competent’’ EpiLCs thenuthor(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
progress toward mPGCLCs, which have the potential to
generate oocytes (Hayashi et al., 2012) and spermatid-like cells
(Zhou et al., 2016). Human PGCLC (hPGCLC) specification
protocols thus far started from already ‘‘germline-competent
pluripotent stem cells’’ (Irie et al., 2015), thereby not fully recapit-
ulating the in vivo hPGC specification and raising the possibility
that key epigenetic steps during the priming phase were missed
(Saitou and Miyauchi, 2016). The recent establishment of naive
hESC culture conditions (Guo et al., 2016; Takashima et al.,
2014; Theunissen et al., 2014, 2016), which more closely
resemble the in vivo state of naive human ICM cells, provides a
promising opportunity to reconstitutemore faithfully hPGC spec-
ification in vitro.
Here we report the establishment of a protocol for in vitro
hPGCLC specification from naive hESCs and investigate the
early events of DNA methylation remodeling prior to and during
PGCLC specification. We have also undertaken a comparative
analysis of epigenetic reprogramming at single base resolution
during human and mouse in vitro germline development and
have identified conserved as well as divergent mechanisms
regulating the observed DNA methylation dynamics. This work
establishes a tractable model system for the precise study of
epigenetic reprogramming in the germline, and describes the
principles and dynamics of DNA methylation remodeling during
early PGC specification.
RESULTS
Generation of Human and Mouse PGCLCs from
Naive ESCs
Using a similar strategy to that described formPGCLC specifica-
tion (Hayashi et al., 2011) we differentiated naive hESCs toward
hEpiLCs in serum-free N2B27 medium containing transforming
growth factor b (TGF-b), basic fibroblast growth factor (bFGF),
and knockout serum replacement (KSR) (Figure 1A). Naive
hESC colonies’ typical domed shape was lost and hEpiLCs
adopted a flat, primed cell morphology by day 4 (Figure 1B), a
characteristic also observed during mPGCLC differentiation
(Hayashi et al., 2011). Next we aggregated hEpiLCs to EBs
(day 0) and induced hPGCLC specification by adding bone
morphogenetic protein 4 (BMP4), stem cell factor (SCF),
epidermal growth factor (EGF), and leukemia inhibitory factor
(LIF). Using a GFP reporter expressed under the control of the
OCT4-dPE promoter (Theunissen et al., 2014) we were able to
monitor the activity of the naive and germ cell-specific OCT4-
dPE promoter (Theunissen et al., 2014; Yeom et al., 1996) in
the EBs, suggesting the formation of hPGCLCs (Figure 1B).
Since previous in vivo studies have shown that hPGC develop-
ment is not completed by week 5.5 (Tang et al., 2015), we aimed
to progress hPGCLC differentiation as far as possible and
achieved the formation and collection of EBs with normal
morphology and no signs of apoptosis until day 12 after induc-
tion. We next used fluorescence-activated cell sorting (FACS)
for cKIT-positive cells to isolate putative hPGCLCs (Figure 1C),
a strategy that has been shown to result in 100% pure germline
cells in vivo (Gkountela et al., 2013, 2015). The hPGCLC popula-
tion expressed key hPGC marker genes such as BLIMP1,
SOX17, or NANOS3 and not SOX2 (Figures 1D–1F), indicating
successful hPGCLC specification.We also generated mPGCLCs as previously described (Fig-
ure S1) (Hayashi et al., 2011). Naive mESCs were differentiated
to mEpiLCs, aggregated to form EBs, and further progressed
toward the mPGC fate using BMP4, SCF, LIF, and EGF, as evi-
denced by the expression of a Blimp1:Venus reporter (Figures
S1A and S1B). Using FACS we were able to isolate mPGCLCs
that expressed Stella:CFP and Blimp1:Venus reporters and/or
were marked by the surface proteins SSEA1 and CD61 (Figures
S1C and S1D). mPGCLCs expressed key PGC marker genes,
such as Stella, Blimp1, or Prdm14, not or only weakly expressed
in EpiLCs (Figure S1E).
We carried out RNA sequencing (RNA-seq) (Table S1) and us-
ing unsupervised hierarchical clustering from human and mouse
naive ESC, primed EpiLCs, and sorted cKIT+ human or SSEA1+/
CD61+ mPGCLCs, found that PGCLCs cluster separately from
naive and primed cells (Figures S1F and S1G). While mPGCLCs
showed a preference to separate by time points, suggesting a
temporal progression, the different hPGCLC time points were in-
termingled, indicating smaller temporal changes. Principal
component analysis (PCA) confirmed these observations (Fig-
ures 1G and 1H) and showed that during specification of
PGCLCs from naive ESCs, some of the transcriptional variance
between naive and primed cells (PC2) was reversed during
primed to PGCLC differentiation, suggesting re-establishment
of a more ‘‘naive’’ transcriptional signature in PGCLCs.
Global Epigenetic Changes during Human and Mouse
PGCLC Specification
To gain insights into epigenetic reprogramming during in vitro
PGCLC specification, we performed whole-genome bisulfite
sequencing of human and mouse PGCLCs and primed EpiLCs
(Table S1), and in our analysis included published in vivo and
in vitro datasets (Ficz et al., 2013; Guo et al., 2014; Okae et al.,
2014; Seisenberger et al., 2012; Takashima et al., 2014; Tang
et al., 2015; Wang et al., 2014) (Figures 2 and S2). After fertiliza-
tion, the highly methylated epigenome of sperm and to a lesser
extent of oocytes is globally erased during progression to ICM
and naive ESCs (29% in hESCs and 31% in mESCs). Subse-
quently, there was a strong de novo methylation activity during
priming of human and mouse EpiLCs, which increased the
average CpG methylation levels to 65% (Figures 2A and 2B),
equivalent to the methylation levels found in mouse epiblast at
E6.5 (Seisenberger et al., 2012).We confirmed this remethylation
using liquid chromatography followed by mass spectrometry,
showing an increase from approximately 1.5%–4% of all cyto-
sines being methylated from the naive ESC state to day-4
hEpiLCs and day-2 mEpiLCs, respectively (Figures S2A and
S2B). We also observed an approximately 2-fold increase in
5-hydroxymethylcytosine (5hmC) levels in mouse and human
EpiLCs compared with naive ESCs. Interestingly, the remethyla-
tion phase during priming took twice as long in humans than in
mice, suggesting a different regulation of the de novo methyl-
ation machinery. In line with increased methylation activity, the
expression levels of the de novo DNMTs 3A and 3B were
upregulated in both mouse and human primed cells, albeit
the increase in mouse was much more pronounced (Figures
2C and S2C).
Next we analyzed epigenetic changes during early PGC spec-
ification. mPGCLCs rapidly lost global methylation, reachingDevelopmental Cell 39, 104–115, October 10, 2016 105
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Figure 1. Specification of hPGCLCs from
Naive Human Embryonic Stem Cells
(A) Schematic protocol for specification of hPGCLCs
from naive hESCs. In brief, naive hESCswere primed
to hEpiLCs for 4 days in the presence of bFGF,
TGF-b, and KSR. Subsequently, day-4 hEpiLCs
were aggregated to EBs and cultured in medium
containing hBMP4, hSCF, hEGF, and hLIF.
(B) Bright-field images of naive hESCs, primed day-4
hEpiLCs, and day-12 hEBs, and fluorescence im-
ages ofOCT4-dPE promoter-driven GFP expression
in hEBs. Scale bars, 200 mm.
(C) FACS analysis of dissociated day 0–12 hEBs with
anti-cKIT-Alexa Fluor 647 to detect hPGCLCs. Box
shows the percentage of cKIT-positive cells at each
time point.
(D) Immunofluorescence of day-12 hEB sections
showing expression of OCT4 (green) or SOX17
(green) and DNA staining with DAPI (blue). Scale
bars, 10 mm.
(E) Immunofluorescence of fixed cKIT+ sorted day-
12 hPGCLCs showing expression of BLIMP1 (green)
and DNA staining with DAPI (blue). Scale bars,
10 mm.
(F) mRNA expression analysis of conventional and
naive hESCs, primed day-4 hEpiLCs, sorted
hPGCLCs, and published in vivo datasets of hPGCs
and somatic cells (Tang et al., 2015). Error bars
indicate mean ± SD from three biological samples.
(G) PCA of RNA-seq data from human naive hESC,
primed day-4 (d4) hEpiLCs, and hPGCLCs. PC1
and PC2 were calculated using the R library
‘‘FactoMineR,’’ excludingvery lowlyexpressedgenes.
(H) PCA of RNA-seq data from mouse naive
mESC, primed day-2 mEpiLCs, and mPGCLCs.
PC1 and PC2 were calculated using the R library
‘‘FactoMineR,’’ excludingvery lowlyexpressedgenes.
See also Figure S1.levels of around 40% CpG methylation after 4 days and 24%
CpG methylation at day 6, similar to in vivo PGCs at E10.5
(28%) or E11.5 (20%) (Seisenberger et al., 2012). In contrast,
hPGCLCs demethylated much more slowly, gradually
decreasing global levels of CpGmethylation from approximately
68% at day 4 to 55% at day 12 (Figures 2A and 2B). In line with
this, previous reports using immunofluorescence to assess
5hmC levels in day-4 hPGCLCs found only a small decline in
5hmC (Irie et al., 2015), while in vivo hPGCs demethylate to
approximately 25% CpG methylation by week 5.5 and reach
their lowest levels of CpG methylation (8%) not before week
7 (Gkountela et al., 2015; Guo et al., 2015; Tang et al., 2015).
On average, therefore, mouse PGC methylation reprogramming
is 5-fold faster than that in human PGCs.106 Developmental Cell 39, 104–115, October 10, 2016The expression of de novo DNMTs was
reduced slightly in human and stronger in
mouse PGCLCs (Figures 2C and S2C)
with further downregulation in in vivo
hPGCs. Transcript levels of the TET pro-
teins, which have been implicated in
imprint erasure in PGCs (Hackett et al.,
2013), were upregulated in hPGCs,
mPGCs, and mPGCLCs but not inhPGCLCs. However, while transcript levels of UHRF1 were
substantially decreased in mPGCLCs and in vivo mPGCs, with
remaining protein being excluded from the nucleus (Seisen-
berger et al., 2012), they were only slightly decreased in
hPGCLCs and UHRF1 protein remained nuclear (Figure S2D).
This differential regulation would result in substantially different
kinetics of passive demethylation inmouse versus human PGCs.
The methylation pattern over genes, with low methylation at
the transcription start sites (TSSs) and slightly increased levels
over gene bodies, was maintained during mouse and human
PGCLC specification (Figures 2D and S2E). DNA methylation
at introns, exons, non-CpG island (CGI)-containing promoters,
or intergenic regions (Figures 2E and S2F) followed the
trend of the whole genome, while non-promoter CGIs and
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Figure 2. DNA Methylation Dynamics during
Human and Mouse PGCLC Specification
(A) Bean plots showing the distribution of CpG
methylation levels of pooled replicates of human
sperm, oocytes, ICM, naive hESCs, primed EpiLCs,
PGCLCs, and in vivo PGCs. Methylation was
quantitated over 20-kb genomic probes covered by
at least ten CpGs.
(B) Bean plots showing distribution of CpG methyl-
ation levels of pooled replicates of mouse sperm,
oocytes, ICM, naive ESCs, epiblast, primed EpiLCs,
PGCLCs, and in vivo PGCs. Methylation was
quantitated over 20-kb genomic probes covered by
at least ten CpGs.
(C) mRNA expression levels of key enzymes
involved in DNA methylation dynamics in human
naive hESCs, primed hEpiLCs, hPGCLCs, and
in vivo PGCs. Heatmap shows the average
expression (log2) of three biological replicates.
(D) Averaged CpG methylation profiles over all hu-
man annotated genes starting from 5 kb upstream
(5 kb) of the transcription start site (TSS), through
scaled gene bodies to 5 kb downstream (+5 kb) of
transcription end site (TES).
(E) Averaged CpGmethylation of indicated genomic
features in the human methylation datasets.
(F) Averaged CpG methylation of known DMRs of
imprintedmaternal and paternal genes in the human
methylation datasets.
(G) k-Means clustering of 2-kb probes of the human
genome, excluding probes overlapping with re-
petitive elements. Seven clusters were generated
and the enrichment of specific genomic features
compared with the whole genomes was assessed.
Published datasets from human sperm, oocytes
(Okae et al., 2014), ICM (Guo et al., 2014), naive
ESCs (Takashima et al., 2014), in vivo PGCs (Tang
et al., 2015), andmouse sperm, oocytes, ICM (Wang
et al., 2014), naive ESCs (Ficz et al., 2013), epiblast,
and in vivo PGCs (Seisenberger et al., 2012) were
included in the analysis. Biological replicates were
pooled and average levels were used for the anal-
ysis. See also Figure S2.CGI-containing promoters remained at low levels of methylation
throughout all time points with a small increase during EpiLC
priming. Next we analyzed themethylation at known differentially
methylated regions (DMRs) of imprinted genes (Figures 2F and
S2G). Methylation of paternal or maternal DMRs was exclusively
found in either sperm or oocytes, respectively; after fertilization
the combined levels were maintained at around 50% into ICM
cells, indicating faithful maintenance of imprinting. Naive mESCs
and mEpiLCs maintained a similar methylation pattern of
imprinted DMRs, which notably were subsequently erased dur-
ing mPGCLC formation, with substantial erasure in day-6
mPGCLCs. In vivo mPGCs also demethylate the imprinted
DMRs, starting around E10.5/E11.5 with complete erasure by
E13.5. In contrast, naive hESCs had erased almost all imprinted
DMRs, as previously reported (Pastor et al., 2016) and, as a
consequence, imprinted DMRs were not re-established during
hEpiLC priming and remained demethylated during hPGCLC
specification at levels comparable with in vivo hPGCs.To identify specific unique regions showing different methyl-
ation dynamics compared with the whole genome during the
early phase of human epigenetic resetting, we performed
k-means clustering of 2-kb probes of the genome (Figure 2G),
excluding probes overlapping with repetitive elements, which
were analyzed separately (Figures 4 and S4). The identified
clusters showed enrichment for specific genomic features, with
clusters 3 and 6 being enriched for intergenic regions andmostly
following closely the global trend of DNA methylation. Clusters 2
and 7 retained low methylation and were enriched in CGIs, with
cluster 2 showing enrichment in promoter and genic CGIs, while
cluster 7 was enriched in intergenic CGIs. Cluster 4 retained
higher levels of DNA methylation even in in vivo hPGCs and,
while no specific enrichment was found, most probes were in
close proximity (<2 kb) to SINE-VNTR-Alu (SVA) or L1Pa repeti-
tive elements. Cluster 1 followed the general methylation pattern
overall but retained slightly higher levels of methylation in
hPGCLCs and was enriched for gene bodies.Developmental Cell 39, 104–115, October 10, 2016 107
Regulation of Local Methylation Dynamics
Having found that the feature composition and proximity to
repetitive elements correlates with the methylation dynamics,
we first compared the local methylation levels of primed day-4
hEpiLCswith day-12 hPGCLCs. The overall methylation distribu-
tion showed that the genome was not demethylated uniformly;
we thus constructed a background model of demethylation
from primed day-4 hEpiLCs to day-12 hPGCLCs and tested for
probes with significantly (p < 0.05) higher (red) or lower (blue)
levels of DNA methylation (Figure 3A).
A subset of probes with significantly lower levels of DNA
methylation in day-12 hPGCLCs overlapped with CGIs, which
remained lowly methylated throughout the whole time course
(compare clusters 2 and 7 in Figure 2G). We then looked for
genomic features overlapping with the more highly methylated
regions (Figure 3A) and found that probes overlapping with
gene bodies or the repetitive elements SVA and L1Pa, which
had previously been found to resist demethylation in in vivo
hPGCs (Tang et al., 2015), retained higher levels of DNA methyl-
ation in day-12 hPGCLCs. This can also be seen in the illustrated
example (Figure 3B), where SVA overlapping probes (green
shading) or gene bodies of ASXL2 or RAB10 (red shading) re-
tained higher levels of methylation, even in in vivo week-5.5
hPGCs. Increased DNMT3B binding and de novo methylation
at transcribed genes has been reported previously (Baubec
et al., 2015) but we did not find a correlation between persistence
of gene body methylation and transcription in day-12 hPGCLCs
(Figure S3A).
We next compared the methylation levels of the probes iden-
tified with significantly higher (red) or lower (blue) levels of DNA
methylation (Figure 3A) across the whole time course of in vitro
hPGCLC specification, including earlier and later in vivo datasets
(Figure 3C). Regions that partially resisted demethylation during
hPGCLC specification (red) showed higher methylation in naive
hESCs and hICM but acquired methylation levels comparable
with that of the whole genome upon priming and remethylation
(day-4 hEpiLCs). During subsequent hPGCLC differentiation,
these regions retained higher levels of methylation until in vivo
week-5.5 hPGCs and only became almost completely demethy-
lated in week-7 hPGCs, indicating that DNA demethylation
kinetics differ significantly across the genome.
To better understand the regulation of local methylation dy-
namics, we performed a similar analysis on the mouse datasets
(Figure 3D) and compared the methylation levels of day-2
mEpiLCs with globally demethylated day-6 mPGCLCs.
A defined set of regions retained high levels of methylation in
mPGCLCs and these were enriched in intracisternal A particle
(IAP) transposable elements (TEs), but there was no enrichment
in gene body methylation as observed in human. As illustrated in
Figure S3B, not all regions that retain methylation in mPGCLCs
(and in vivo mPGCs) are IAP associated. We therefore overlaid
the methylation comparison with available chromatin immuno-
precipitation sequencing (ChIP-seq) data from day-6 mPGCLCs
(Kurimoto et al., 2015) or in vivo mPGCs (Liu et al., 2014).
Regions retaining high levels of DNA methylation were enriched
in the repressive histone marks histone 3 lysine 9 trimethylation
(H3K9me3) or H3K9me2 (Figures 3D and S3C), which have
been shown to play a pivotal role in recruitment of the DNA
methylation machinery (Citterio et al., 2004; Karagianni et al.,108 Developmental Cell 39, 104–115, October 10, 20162008; Rothbart et al., 2012). Conversely, regions with low levels
of DNA methylation in day-6 mPGCLCs were enriched in the
activating histone marks H3K4me3 or H3K27ac (Figures 3D
and S3C).
The transcript levels of the H3K9 methylases EHMT1 and
EHMT2 were reduced in PGCLCs and in vivo PGCs of both spe-
cies, while the expression of the H3K9 demethylases KDM3A
and KDM3B was increased in only mPGCLCs and in vivo
PGCs of both species (Figures 3E andS3D), but not in hPGCLCs.
Regulation of Transposable Elements in PGCLCs
About half of the mammalian genome is composed of inter-
spersed repetitive elements resulting from replicative insertion
events of TEs (Burns and Boeke, 2012; Lander et al., 2001;
Mouse Genome Sequencing Consortium et al., 2002). DNA
methylation is important for TE repression in somatic cells, and
other mechanisms including histone modifications or PIWI-inter-
acting RNAs (piRNAs) control TEs upon global demethylation
(Friedli and Trono, 2015; Iwasaki et al., 2015). We analyzed the
average methylation levels of major classes of human and
mouse TEs, including long and short interspersed elements
(LINEs and SINEs), long terminal repeats, human SVA retrotrans-
posons, and mouse IAPs (the most active murine TE class).
All TEs gainedmethylation during priming from naive hESCs to
hEpiLCs and only became demethylated slowly during hPGCLC
specification (Figure 4A), with SVA elements retaining most
methylation, while in vivo hPGCs showed demethylation with
only SVA and human endogenous retrovirus K (hERVK) TEs re-
taining some methylation at week 7 (Tang et al., 2015). Naive
hESCs showed high expression of SVA TEs but transcription of
TEs was generally low in hPGCLCs and hPGCs, with the excep-
tion of hERVK elements, which showed some expression in all
datasets (Figure S4A).
In contrast, there was extensive demethylation of TEs during
mPGCLC development (Figure 4B), again resembling levels of
in vivo mPGCs around E10.5/E11.5. IAPs retained higher levels
of methylation in vitro, as they do in vivo. Analysis of poly(A)-en-
riched RNA-seq datasets (Figure 4C) showed increased expres-
sion of IAPs and ERVK in day-6mPGCLCs. Transcription of other
TEs remained low in all mPGCLC datasets, suggesting that addi-
tional repressive mechanisms are controlling TE expression.
Previous studies using total RNA-seq have also shown increased
TE expression in hypomethylated in vivo mPGCs and an involve-
ment of piRNAs in controlling TE expression (Molaro et al., 2014).
piRNAs are germline-specific 24- to 31-nt-long small RNAs
(smRNAs) which have been shown to regulate the activity of
TEs in the germline (Aravin et al., 2007). Due to the lack of
suitable mammalian experimental models, the mechanisms
controlling the generation of mature piRNAs and their molecular
TE-silencing activity are still enigmatic (Iwasaki et al., 2015).
Notably, mPGCLCs do express the relevant enzymes required
for piRNA biogenesis and activity, namely Miwi2 and Mili
(Figure 4D) while expression of MILI and MIWI2 in hPGCLC is
lower than in in vivo hPGCs (Figure S4B), perhaps as a conse-
quence of the fact that TEs are not yet demethylated and hence
not prone to transcriptional activation.
We generated small RNA-seq libraries from mPGCLCs and
in vivo E15.5 male prospermatogonia (Table S1) to assess
the expression of piRNAs. mPGCLCs and prospermatogonia
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Figure 3. Regulation of Local Methylation Dynamics during Human and Mouse PGCLC Specification
(A) Scatter plots of CpGmethylation percentages over probes spanning 50CpGs comparing primed day-4 hEpiLCs and day-12 hPGCLCs. The scatter plots were
overlaid with red or blue to highlight probes with higher or lower levels of CpG methylation than the background model (p < 0.05) or labeled to highlight CpG
density, overlap with gene bodies, SVA, or L1Pa elements.
(B) Representative bisulfite-sequencing data showing a part of chromosome 2 from hICM, hESC, primed hEpiLC, hPGCLC, and in vivo hPGC datasets. Regions
retaining higher levels of DNA methylation and overlapping with SVA elements or gene bodies are shaded in green or red, respectively. The position of genes,
CGIs, and SVA or L1PA elements is shown in the top panel.
(C) Box plots of the CpG methylation levels of probes defined in (A) as methylated higher or lower than the background model. Shown are samples across the
whole hPGC/hPGCLC specification period. The middle line indicates the median of the data, the upper and lower extremities of the box show the 25th and 75th
percentiles, and the upper and lower black whiskers show the median ± the interquartile range (25%–75%) multiplied by 2. Any individual points that fall outside
this range are shown as filled circles. Each circle represents a single probe.
(legend continued on next page)
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showed strong enrichment in 24- to 31-nt-long smRNAs with
high numbers mapping to gene-derived piRNAs (Li et al., 2013)
and >50% of all smRNAs mapping to TEs (Figures 4E, 4F, and
S4C). In contrast, mESC-derived smRNAs were mostly 22–23-
nt-long microRNAs (miRNAs). Furthermore, we found character-
istics of piRNAs (Iwasaki et al., 2015) in the smRNAs from
mPGCLC and prospermatogonia samples that mapped to
repetitive elements (defined by repeatmasker): smRNAs map-
ping to TEs had a tendency for U at the 50 end (Figures 4G and
S4D) and also a high frequency of exactly 10-nt spaced 50 to 50
overlaps (‘‘ping-pong signature’’) (Figure 4H). Similarly, we found
high numbers of smRNAs mapping both sense and antisense to
repetitive elements in mPGCLCs (Figure 4I). Notably, therefore,
in vitro mPGCLCs express transposon-derived piRNAs at levels
comparable with those of in vivo prospermatogonia.
DISCUSSION
Global DNA demethylation is a key characteristic of mammalian
PGC (and early embryo) development and allows the germ cell
lineage to create a blank slate (‘‘tabula rasa’’) (Clark, 2015) with
an underlying pluripotent characteristic, possibly a prerequisite
for the subsequent generation of the totipotent zygote (Reik
and Surani, 2015). Here we have developed a protocol for
hPGCLC formation from naive ESCs, hence recapitulating in vivo
priming and specification, and studied the early events of DNA
methylation reprogramming in human and mouse PGCLCs.
This approach has also allowed us to characterize the DNA
methylation changes during the initial priming phase toward
EpiLCs, which formed the basis for the subsequent demethyla-
tion during PGCLC specification, and to obtain insights into the
regulation of epigenetic resetting in human and mouse. Notably,
there are some key differences in the regulation of epigenetic
modifiers, which may underlie the very different reprogramming
kinetics in human and mouse.
We discovered that human and mouse PGCLCs can be
induced from naive pluripotent stem cells using similar method-
ologies, despite the fact that the transcriptional networks
regulating human and mouse PGC specification differ in several
aspects (Saitou and Miyauchi, 2016). Notably, in vitro hPGCLC
development was significantly delayed compared withmPGCLC
specification, which is in agreement with the different develop-
mental timing in vivo (Irie et al., 2014). Interestingly, the rate of
de novo methylation during priming to EpiLCs was approxi-
mately twice as fast in mouse as in human, although the final
methylation levels were comparable. This correlated with strong
upregulation of all de novo Dnmts in the mouse, while human
primed cells only showed a modest increase in DNMT3A and
DNMT3B expression and a decrease in DNMT3L mRNA levels,(D) Scatter plots of CpGmethylation percentages over probes spanning 50CpGs c
overlaid with red or blue to highlight probes with higher or lower levels of CpGmeth
the density of overlapping IAPs. Published histone ChIP-seq datasets for H3K9m
the respective marks, according to their ChIP-seq read-count enrichment.
(E) Expression of histone 3 lysine 9 methyltransferases (KMTs) and demethylase
mPGC datasets. Suv39h1/2 and Kdm4a/b/c are H3K9me3 specific, while Ehmt1
expression (log2) of three biological replicates.
Published datasets from human ICM (Guo et al., 2014), naive ESCs (Takashima e
et al., 2012) and ChIP-seq (Kurimoto et al., 2015; Liu et al., 2014) were included in t
the analysis. See also Figure S3.
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methylation kinetics during priming. Similarly, the rate of global
DNA demethylation was slower in hPGCLCs, reaching 55%
CpG methylation after 12 days compared with 25% CpG
methylation in day-6 mPGCLCs. In human this represents early
demethylation steps not captured in vivo so far (Gkountela
et al., 2015; Guo et al., 2015; Tang et al., 2015) while in mouse
the end point corresponds to late migratory (E10.5/E11.5)
mPGCs (Seisenberger et al., 2012). Hence, taking both in vitro
and in vivo data into account it appears that demethylation in
mouse PGCs is five times as fast as in human ones, which is un-
likely to be solely due to different rates of cell proliferation.
Mechanistically, some of these global differences may instead
be explained by species- and stage-specific regulation of the
DNA maintenance methylation machinery. mPGCLCs (and
mPGCs) repress Uhrf1 strongly at the transcriptional level, while
hPGCLCs show only weak repression. In hPGCs, however,
UHRF1 is repressed at the transcript level and strongly at the
protein level (Gkountela et al., 2015; Guo et al., 2015; Tang
et al., 2015), suggesting that impairment of DNA maintenance
methylation varies between different stages of hPGC develop-
ment. Remaining UHRF1 protein was found to be excluded
from the nucleus in mPGCs (Seisenberger et al., 2012) while in
hPGCLCs and hPGCs it remains nuclear (Irie et al., 2015; Tang
et al., 2015).
Prdm14 has been shown to be critical for mouse PGC devel-
opment (Yamaji et al., 2008) and, together with Blimp1, is impli-
cated in the transcriptional repression of de novo Dnmts and
Uhrf1 (Nakaki and Saitou, 2014). During hPGC development
upregulation of PRDM14 is delayed compared with other germ
cell genes (Irie et al., 2015; Tang et al., 2015), whichmight explain
the species-specific temporal differences in the regulation of de
novo DNMTs and UHRF1.
Maintenance methylation is regulated by synergistic action of
UHRF1 and H3K9me2 and H3K9me3, so it was interesting to
note that both mPGCLCs and mPGCs showed repression of
Ehmt1 and 2 (H3K9 methylases) and increased expression of
Kdm3a and 3b (H3K9 demethylases), potentially driving loss
of H3K9 methylation together with reduced recruitment of
UHRF1 to the replication fork and ensuing erosion of DNA
maintenance methylation (von Meyenn et al., 2016). During
hPGCLC specification, EHMT1 and EHMT2 expression was
also reduced but KDM3A and KDM3B expression was only
increased in hPGCs, suggesting that loss of H3K9me2 is also
slower in hPGC development. Hence there is apparently a
finely tuned system of differential regulation of de novo and
of maintenance methylation modifiers that results in consider-
ably slower epigenetic reprogramming kinetics in human versus
mouse PGCs.omparing primed day-2mEpiLCs and day-6mPGCLCs. The scatter plots were
ylation than the backgroundmodel (p < 0.05) or labeled by their CpG density or
e2, H3K9me3, H3K27ac, and H3K4me3 were used to label probes enriched in
s (KDMs) in mouse naive mESC, primed day-2 mEpiLC, mPGCLC, and in vivo
/2 and Kdm3a/b are specific for H3K9me1/2. The heatmap shows the average
t al., 2014), in vivo PGCs (Tang et al., 2015), mouse in vivo PGCs (Seisenberger
he analysis. Biological replicates were pooled and average levels were used for
AE
B
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Figure 4. Methylation Dynamics and Tran-
scriptional Regulation of Transposable
Elements
(A) Averaged CpG methylation of major human re-
petitive elements in human datasets.
(B) Averaged CpG methylation of major murine re-
petitive elements in mouse datasets.
(C) Averaged expression of major murine repetitive
elements in mouse poly(A)-enriched RNA-seq
datasets. Repeat locations were extracted from the
pre-masked repeatmasker libraries and repeat in-
stances within 2 kb of an annotated gene were
removed.
(D) Expression of key enzymes involved in smRNA
biogenesis and function in mouse naive mESCs,
primed day-2 mEpiLCs, mPGCLCs, and in vivo
mPGCs. The heatmap shows the average expres-
sion (log2) of biological replicates.
(E) Distribution of reads from smRNA-seq libraries
from day-6 mPGLCLs, in vivo prospermatogonia,
and mESCs over different classes of smRNAs as
defined previously (Han et al., 2015; Li et al., 2013).
smRNAs mapping to (gene-derived) piRNAs are
highlighted.
(F) Length distribution of all uniquely mapped
smRNAs, excluding rRNAs, in day-6 mPGCLCs.
The average length of miRNAs (22 nt) and piRNAs
(24–31 nt) is highlighted.
(G) Nucleotide composition of the 50 ends ± 30 nt
of all smRNAs from day-6 mPGCLCs uniquely
mapped to repetitive elements (defined by re-
peatmasker).
(H) Ping-pong (50 to 50 overlap) analysis of normal-
ized reads from day-6 mPGCLCs mapped to
repetitive elements (defined by repeatmasker).
(I) Length distribution of smRNAs from day-6
mPGCLCs assigned to sense (blue) and antisense
(red) strands of reads uniquely mapped to repetitive
elements (defined by repeatmasker).
Published datasets from human sperm, oocytes
(Okae et al., 2014), ICM (Guo et al., 2014), naive
ESCs (Takashima et al., 2014), in vivo PGCs (Tang
et al., 2015), and mouse sperm, oocytes, ICM
(Wang et al., 2014), naive ESCs (Ficz et al., 2013),
epiblast, and in vivo PGCs (Seisenberger et al.,
2012) were included in the analysis. Biological rep-
licates were pooled and average levels were used
for the analysis. See also Figure S4.Demethylation was, however, not uniform across the genome.
Regions overlapping with young and active TEs (Friedli and
Trono, 2015) partially resist DNA demethylation in PGCLCs, as
they do in in vivo PGCs (Gkountela et al., 2015; Guo et al.,
2015; Kobayashi et al., 2013; Seisenberger et al., 2012; Tang
et al., 2015). IAPs, which are the youngest and most active TEs
in themouse germline, aremost resistant to demethylation, while
none of the human TE families were as resistant, consistent with
human TEs being more endogenized (Friedli and Trono, 2015). In
addition to TEs, we found a strong correlation of H3K9me2/3
enrichment at regions with retained DNA methylation during
mPGCLC specification and, conversely, an enrichment of
H3K4me3 and H3K27ac at regions with faster than average
demethylation. This suggests that the underlying chromatin
signature influences both the global and the local demethylation
rate in mouse germline development.Loss of DNA methylation has generally been linked to activa-
tion of retrotransposons (Bourc’his and Bestor, 2004; Walsh
et al., 1998), and in vivo piRNAs have been found to control
TE expression (Iwasaki et al., 2015). Indeed, TE expression
was low in substantially hypomethylated day-6 mPGCLCs
and we found expression of piRNAs in in vitro mPGCLCs, sug-
gesting that TE expression is also restrained by smRNA-depen-
dent mechanisms in vitro. Since loss of piRNA activity causes
male sterility (Carmell et al., 2007; Cheng et al., 2014; Kuramo-
chi-Miyagawa et al., 2004), mPGCLCs would seem to represent
a good experimental system for the investigation of piRNA
biology in the future. In hPGCLCs we found some extent of
hERVK reactivation followed by progressive repression in
hPGCs, also suggesting the activity of a DNA methylation-inde-
pendent repressive mechanism in the human germline.
Notably, we also observed a specific increase in the expressionDevelopmental Cell 39, 104–115, October 10, 2016 111
of SVA elements in naive hESC but not in similarly hypomethy-
lated week-5.5 hPGCs, suggesting that the expression of SVA
might be a specific marker of naive hESCs (Theunissen et al.,
2016).
We found a loss of primary methylation imprints in naive
hESCs (confirming a recent study [Pastor et al., 2016]), which
were not re-established during priming to hEpiLCs. Abnormal
imprinting is linked to a range of human developmental disorders
and malignancies (Butler, 2009). While it is hoped that future de-
velopments of naive hESC derivation and culture protocols will
resolve this issue, especially for the application of hESCs,
whether there are any adverse implications of loss of imprinting
for germline development is unclear at present. Finally, the
current PGCLC system enables the characterization of early
events of epigenetic reprogramming and its regulation in the
mammalian germline, but further developments are required to
also capture the later events of human PGC development. These
will reveal the regulation and importance of piRNAs in the human
germline and also shed light on the subsequent events of epige-
netic reprogramming not assessed thus far.
EXPERIMENTAL PROCEDURES
Human hESC Culture and hPGCLC Differentiation
Naive H9 and naive WIBR3 OCT4-dPE-GFP hESCs were propagated in
serum-free N2B27 medium (N2 & B27; Life Technologies) supplemented
with 20 ng/mL hLIF (Cambridge Stem Cell Institute [SCI]), 1 mM MEK inhibitor
PD0325901 (SCI), 3 mM GSK3 inhibitor CHIR99021 (SCI), and 2 mM protein ki-
nase C inhibitor Go¨6983 (Sigma-Aldrich), as described previously (Guo et al.,
2016; Takashima et al., 2014). The medium was refreshed every day and cells
were passaged every 4–5 days. hEpiLC were induced by plating 23 105 naive
hESCs on a well of a 6-well plate coated with growth factor reduced Matrigel
(Corning) in N2B27 medium supplemented with 1 ng/mL TGF-b1 (Peprotech),
12 ng/mL bFGF (SCI), and 1% KSR (Gibco). The medium was changed every
day. hPGCLCswere induced by plating 3–43 103 day-4 hEpiLCs in awell of an
Ultra-Low attachment U-bottom 96-well plate (Corning) in GK15 medium
(Glasgow’s minimal essential medium [Life Technologies] with 15% KSR
[Life Technologies], 0.1 mM non-essential amino acids, 2 mM L-glutamine,
1 mM sodium pyruvate, and 0.1 mM b-mercaptoethanol) supplemented with
500 ng/mL hBMP4 (R&D Systems), 20 ng/mL hLIF (SCI), 100 ng/mL hSCF
(R&D Systems), and 50 ng/mL hEGF (R&D Systems). Cells were cultured in
5% O2 and 5% CO2 in a humidified incubator at 37
C.
Mouse mESC Culture and mPGCLC Differentiation
Naive E14 or BVSCmESCs were cultured feeder-free in N2B27 supplemented
with 10 ng/mL mLIF (SCI), 1 mM MEK inhibitor PD0325901 (SCI), and 3 mM
GSK3 inhibitor CHIR99021 (SCI), together known as 2i (Ying et al., 2008).
The medium was refreshed every day and cells were passaged every
2–3 days. mEpiLC were induced by plating 1 3 105 naive mESCs on a well
of a 12-well plate coated with human plasma fibronectin (Millipore, FC010) in
N2B27 medium supplemented with 20 ng/mL activin A (SCI), 12 ng/mL
bFGF (SCI), and 1% KSR (Gibco) (Hayashi et al., 2011). The medium was
changed every day. mPGCLCs were induced by plating 2 3 103 day-2
mEpiLCs in a well of an Ultra-Low attachment U-bottom 96-well plate
(Corning) in GK15 medium supplemented with 500 ng/mL BMP4 (R&D
Systems), 10 ng/mL mLIF (SCI), 100 ng/mL mSCF (R&D Systems), and
50 ng/mL mEGF (R&D Systems). mPGCLC were cultured in 5% O2 and 5%
CO2 in a humidified incubator at 37
C.
In Vivo Prospermatogonia Collection
Embryonic samples were collected from timed mattings of C57Bl/6J female
mice expressing an Oct-4/GFP transgene in the developing gonad (Yoshimizu
et al., 1999). Prospermatogonia were isolated as described previously (Seisen-
berger et al., 2012). All animal work carried out as part of this study is covered112 Developmental Cell 39, 104–115, October 10, 2016by a project license (to W.R.) under the 1986 Animal (Scientific Procedures)
Act, and is further regulated by the Babraham Institute Animal Welfare, Exper-
imentation, and Ethics Committee.
RNA-Seq, Mapping, and Analysis
Extracted total RNA was DNase treated and poly(A) enriched. RNA-seq
libraries were prepared using the TruSeq RNA Library Prep Kit v2 (Illumina)
or a modified SMART-Seq2 protocol (Picelli et al., 2014). Sequencing was
performed on Illumina HiSeq 2000 instruments and RNA-seq sequences
were trimmed using Trim Galore (v0.4.1, http://www.bioinformatics.
babraham.ac.uk/projects/trim_galore/) using default settings. Trimmed data
were separately mapped to the human GRCh37 or mouse GRCm38 genome
assemblies using hisat2 (v2.0.5) with options –sp 1000,1000 –no-mixed –no-
discordant, and filtered to remove non-primary alignments or alignments
with MAPQ <20. Mapped RNA-seq data were quantitated using the RNA-seq
quantitation pipeline in SeqMonk software (www.bioinformatics.babraham.ac.
uk/projects/seqmonk/).
small RNA-Seq, Mapping, and Analysis
smRNA-seq libraries were generated using the Illumina TruSeq Small RNA
Library Preparation Kit (RS-200-0012) with the following modifications. A total
of 100 ng to 1 mg RNA input material was used. cDNA samples were run on
10% Novex PAGE gels for purification and the gel piece between the 145-
and 160-bp marker excised, and cDNA was eluted from the gel in freshly
prepared 0.3 M NaCl by rotation overnight at 4C. The cDNA was precipitated
in EtOH overnight; from the supernatant the cDNA was resuspended in 10 mL
of EB buffer and the library was quantified using the high-sensitivity DNA chips
on the Agilent Bioanalyzer. High-throughput sequencing of all libraries was
carried out with single-end protocols on a HiSeq 2000 instrument (Illumina).
smRNA-seq data processing was performed using the freely available
piRNA pipeline piPipes (https://github.com/bowhan/piPipes) (Han et al.,
2015). smRNA-seq libraries were trimmed to remove poor-quality reads,
adapters, and barcode sequences. Trimmed data were mapped using Bowtie
against the mm9 genome build and specific relevant annotations: Gene-
derived piRNA annotations were defined earlier (Li et al., 2013) and based
on experimental data from mouse spermatogenesis. Repeats were defined
in the analysis by using the mouse repeatmasker annotation (http://www.
repeatmasker.org).
The plots shown were generated as described below. The distribution of
smRNAs was computed by mapping all smRNA-seq reads to the individual
genomic features. Unannotated reads were not shown in the graph. The length
distribution was calculated taking all uniquely mapped smRNAs into account,
excluding smRNAs mapping to rRNAs.
For all subsequent analysis, smRNA reads were pre-filtered as follows:
reads mapping to rRNAs and miRNAs were excluded, then reads aligning to
the repeat masked mm9 genome (all annotated repeats were masked/re-
placed by Ns) were also removed. The remaining smRNA reads were mapped
to the mouse repeatmasker annotation. The 50-end nucleotide composition
was computed from the uniquely mapped smRNA. Similarly, analysis of the
position of 50 to 50 overlap was performed on the mapped smRNA reads,
and the length distribution and strand orientation of smRNAs shown was
generated using uniquely mapped smRNA reads.
Bisulfite Sequencing, Mapping, and Analysis
Whole-genome bisulfite libraries were generated from isolated DNA following
published protocols (Seisenberger et al., 2012) or post-bisulfite adaptor
tagging (PBAT) libraries were prepared directly from cell lysates following
recently described protocols (Miura et al., 2012; Smallwood et al., 2014).
High-throughput sequencing of all libraries was carried out with a 125-bp
paired-end protocol on a HiSeq 2000 instrument (Illumina).
Raw sequence reads from PBAT libraries were trimmed to remove
poor-quality reads and adapter contamination using Trim Galore (v0.4.1).
The remaining sequences were mapped using Bismark (v0.14.4) (Krueger
and Andrews, 2011) with the following set of parameters to the mouse
reference genome GRCm38 or the human reference genome GRCh37 in
paired-end mode: –pbat to be able to count overlapping parts of the reads
only once while writing out unmapped singleton reads; in a second step re-
maining singleton reads were aligned in single-end mode for read 1: –pbat;
or single-end mode for read 2: defaults. Reads were then deduplicated and
CpG methylation calls were extracted from the deduplicated mapping output
ignoring the first 6 bp of each read to reduce the methylation bias typically
observed in PBAT libraries using the Bismark methylation extractor (v0.14.4)
with the following parameters: (a) paired-end mode: –ignore 6 –ignore_r2 6;
(b) single-end mode: –ignore 6.
Raw sequence reads from WBGS libraries were trimmed to remove
poor-quality reads and adapter contamination using Trim Galore (v0.4.1).
The remaining sequences were mapped using Bismark (v0.14.4) (Krueger
and Andrews, 2011) with default parameters to the mouse reference genome
GRCm38 or the human reference genome GRCh37 in paired-end mode.
Reads were then deduplicated and CpG methylation calls were extracted
from the deduplicated mapping output using the Bismark methylation
extractor (v0.14.4) in paired-end mode.
CpG methylation calls were analyzed using R and SeqMonk software.
Global CpG methylation levels of pooled replicates were illustrated using
bean plots. The genome was divided into consecutive 20-kb probes covered
by at least 10 CpGs, and percentage methylation was calculated using the
bisulfite feature methylation pipeline in SeqMonk.
Probe trend plots were generated by calculating average CpG methylation
levels of 1-kbp 500-bp overlapping probes from 5 kbp upstream of the tran-
scriptional start site through gene bodies (which were scaled for visualization)
to 5 kbp downstream of the transcriptional end site.
For analysis of specific genome features, these were defined as follows us-
ing the Ensembl gene set annotations for mouse and human: exons (probes
overlapping exons), introns (probes overlapping introns), promoters (probes
overlapping 1,000 bp upstream of genes), CGI promoters (promoters contain-
ing or within 250 bp of a CGI), non-CGI promoters (all other promoters), inter-
genic (probes not overlapping with gene bodies). Annotations for mouse and
human germline imprint control regions were obtained from Tomizawa et al.
(2011) and Court et al. (2014). Pseudocolor heatmaps representing average
methylation levels were generated using the R ‘‘heatmap.2’’ function without
further clustering, scaling, or normalization.
For k-means clustering, average CpG methylation across 2-kb probes of
the human genome were calculated using the bisulfite feature methylation
pipeline in SeqMonk, excluding probes overlapping with repetitive elements.
Seven clusters were generated, and enrichment of specific genomic features
was assessed by counting the percentage overlap of probes in each cluster
with the specific genomic features and comparing these with the whole
genome.
Scatter plots visualizing the changes in global methylation were generated
by plotting the percentage methylation over probes defined to contain 50
CpGs each. Scatter plots were colored according to the probe density or
the density of the indicated overlapping genomic feature. Published raw
ChIP-seq data were trimmed to remove poor-quality reads, adapters, and bar-
code sequences using Trim Galore (v0.4.1). Trimmed data were mapped using
Bowtie2 against the mouse reference genomeGRCm38 and filtered to remove
non-primary alignments or alignments with MAPQ <20. Read-count enrich-
ments were overlaid on the methylation scatter plots. Pseudocolor scatter
plots were generated using R.
Correlation between gene body methylation and gene expression was
computed from average CpG methylation across gene bodies using the bisul-
fite feature methylation pipeline in SeqMonk and correlating these values with
the respective gene expression values for each gene.
Repeat Analysis
Repeat locations for a pre-defined set of repeat classes of interest were ex-
tracted from the pre-masked repeatmasker libraries (mouse, repeatmasker
v4.0.3, library version 20130422; human, repeatmasker v4.0.5, library version
20140131). Repeat instances within 2 kb of an annotated gene in the Ensembl
gene set were removed to avoid mixing signals from genic expression with
specific expression of repetitive sequences.
RNA-seq sequences were processed and mapped as described above
(RNA-Seq, Mapping, and Analysis). Non-directional overlaps were quantitated
between the mapped RNA-seq reads and the repeat instances. Summed
counts for all instances of each class of repeat were calculated, and these
were corrected for both the total length of all repeats and the size of the indi-
vidual libraries to generate RPKM (reads per kilobase of transcript per millionmapped reads) expression values. The matrix of expression values and sam-
ples was plotted using the R pheatmap library.
Bisulfite sequencing libraries were processed and mapped as described
above (Bisulfite Sequencing, Mapping, and Analysis). Methylation levels at
the repeat instances were quantitated by summing up all methylation calls
and non-methylation calls for all instances of each class of repeat and
calculating the percentage of methylated calls over all calls. The matrix
of expression values and samples was plotted using the R pheatmap
library.
See also Supplemental Experimental Procedures.
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Note Added in Proof
During the revision of this manuscript another study reported global loss of
DNA methylation and imprint erasure in in vitro mPGCLCs (Miyoshi et al.
2016), supporting the usefulness of the PGCLC system and confirming our
observations. REF: Miyoshi, N., Stel, J. M., Shioda, K., Qu, N., Odahima, J.,
Mitsunaga, S., et al. (2016). Erasure of DNA methylation, genomic imprints,
and epimutations in a primordial germ-cell model derived from mouse plurip-
otent stem cells. Proceedings of the National Academy of Sciences of the
United States of America. http://doi.org/10.1073/pnas.1610259113.Developmental Cell 39, 104–115, October 10, 2016 115
